NCT04726267

Brief Summary

Intraocular surgery could induce vitreous degeneration and posterior vitreous detachment (PVD). Vitreomacular interface (VMI) abnormalities usually are caused by abnormal PVD, vitreoschisis and partial-thickness PVD. Furthermore, the PVD could induce the peripheral break. The incidence of peripheral break and epimacular membrane (EMM) after pneumatic retinopexy were 11.7% and 4-11%, respectively. Although multiple intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections induced PVD of 5.6%, but peripheral break was reported as only 0.67%. The most common intraocular surgery is cataract surgery. From the literature review, many methods were used to detect the PVD after phacoemulsification. The former studies used indirect ophthalmoscopy and ocular ultrasound for diagnosis of PVD. The later studies used the optical coherence tomography (OCT) for PVD detection. The OCT device had higher effectiveness in evaluation of the posterior segment, then it can detect post-phacoemulsification PVD more and early than previous studies. Ivastinovic et al demonstrated 59.2% of patients had PVD at 1 month after phacoemulsification, and increased up to 71.4% at 3 months. The incidence of rhegmatogenous retinal detachment (RRD) after phacoemulsification is gradually increased with time. The accumulative risk of RRD was increased from 0.27% at 1 year to 1.27% at 20 years after phacoemulsification.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 23, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 27, 2021

Completed
5 months until next milestone

Study Start

First participant enrolled

July 1, 2021

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
Last Updated

June 30, 2021

Status Verified

June 1, 2021

Enrollment Period

2.5 years

First QC Date

January 23, 2021

Last Update Submit

June 29, 2021

Conditions

Keywords

posterior vitreous detachmenttrabeculectomyvitreomacular interface

Outcome Measures

Primary Outcomes (1)

  • Incidence of PVD

    complete PVD

    12 months

Secondary Outcomes (1)

  • The incidence of VMI abnormalities

    12 months

Study Arms (1)

Glaucoma patients who was scheduled for trabeculectomy

OTHER

Wide-field OCT was performed 1-2 weeks before the trabeculectomy. The OCT was done postoperatively at 1 month, 3 months, 6 months and 12 months after surgery.

Device: Wide-field optical coherence tomography

Interventions

Merged 4 images of wide-field optical coherence tomography, 2 images of vertical scan and 2 images of horizontal scan.

Glaucoma patients who was scheduled for trabeculectomy

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Primary open angle glaucoma or primary angle closure glaucoma
  • Age 18-65 years
  • Could be taken the wide-field OCT images
  • Written informed consent

You may not qualify if:

  • History of intraocular inflammation or infection
  • History of ocular trauma or head trauma
  • History of intraocular surgery such as intravitreal drug injection and cataract surgery
  • History of vitreoretinal diseases such as diabetic retinopathy, retinal vascular occlusion and age-related macular degeneration
  • History of laser treatment including laser capsulotomy and retinal photocoagulation
  • High myopia; spherical equivalence \>4 diopters
  • Complete PVD was detected before the enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Khon Kaen University

Khon Kaen, 40002, Thailand

Location

MeSH Terms

Conditions

Vitreous Detachment

Condition Hierarchy (Ancestors)

Eye Diseases

Study Officials

  • Suthasinee Sinawat, MD

    KKU Eye Center, Department of Ophthalmology, Faculty of Medicine, Khon Kaen University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Suthasinee Sinawat, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
KKU Eye Center, Department of Ophthalmology

Study Record Dates

First Submitted

January 23, 2021

First Posted

January 27, 2021

Study Start

July 1, 2021

Primary Completion

December 30, 2023

Study Completion

June 30, 2024

Last Updated

June 30, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will not share

Locations